The Anglo-Swedish drugmaker said it was fixing problems with the manufacturing of its Covid-19 vaccine and expects to roughly double monthly production to 200 million doses by April.
The Anglo-Swedish drugmaker said it was fixing problems with the manufacturing of its Covid-19 vaccine and expects to roughly double monthly production to 200 million doses by April.
Share this Article
Comment on this Article
Recommended
Please to comment